244 related articles for article (PubMed ID: 12097764)
1. Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis.
Grassi C; Salvatori E; Rosignoli MT; Dionisio P;
Respiration; 2002; 69(3):217-22. PubMed ID: 12097764
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily.
Chodosh S; Lakshminarayan S; Swarz H; Breisch S
Antimicrob Agents Chemother; 1998 Jan; 42(1):114-20. PubMed ID: 9449270
[TBL] [Abstract][Full Text] [Related]
3. Prulifloxacin versus ciprofloxacin in the treatment of adults with complicated urinary tract infections.
Carmignani G; De Rose AF; Olivieri L; Salvatori E; Rosignoli MT; Dionisio P
Urol Int; 2005; 74(4):326-31. PubMed ID: 15897698
[TBL] [Abstract][Full Text] [Related]
4. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis.
Blasi F; Schaberg T; Centanni S; Del Vecchio A; Rosignoli MT; Dionisio P
Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
DeAbate CA; Bettis R; Munk ZM; Fleming H; Munn NJ; Riffer E; Bagby B; Giguere G; Collins JJ
Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
[TBL] [Abstract][Full Text] [Related]
6. Prulifloxacin: a new fluoroquinolone for the treatment of acute exacerbation of chronic bronchitis.
Cazzola M; Salvatori E; Dionisio P; Allegra L
Pulm Pharmacol Ther; 2006; 19 Suppl 1():30-7. PubMed ID: 16359895
[TBL] [Abstract][Full Text] [Related]
7. Prulifloxacin.
Keam SJ; Perry CM
Drugs; 2004; 64(19):2221-34; discussion 2235-6. PubMed ID: 15456336
[TBL] [Abstract][Full Text] [Related]
8. A double-blind study of once-daily temafloxacin in the treatment of bacterial lower respiratory tract infections.
Kosmidis J
J Antimicrob Chemother; 1991 Dec; 28 Suppl C():73-9. PubMed ID: 1664832
[TBL] [Abstract][Full Text] [Related]
9. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
DeAbate CA; Henry D; Bensch G; Jubran A; Chodosh S; Harper L; Tipping D; Talbot GH
Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
Langan CE; Cranfield R; Breisch S; Pettit R
J Antimicrob Chemother; 1997 Dec; 40 Suppl A():63-72. PubMed ID: 9484875
[TBL] [Abstract][Full Text] [Related]
11. Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Α Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice-The "AIOLOS" Study.
Gourgoulianis K; Ruggieri A; Del Vecchio A; Calisti F; Comandini A; Esposito G; Di Loreto G; Tzanakis N
Can Respir J; 2021; 2021():6620585. PubMed ID: 34122678
[TBL] [Abstract][Full Text] [Related]
12. Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group.
Anzueto A; Niederman MS; Tillotson GS
Clin Ther; 1998; 20(5):885-900. PubMed ID: 9829441
[TBL] [Abstract][Full Text] [Related]
13. Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa.
Roveta S; Schito AM; Marchese A; Schito GC
Int J Antimicrob Agents; 2005 Nov; 26(5):366-72. PubMed ID: 16216467
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis.
Read RC; Kuss A; Berrisoul F; Kearsley N; Torres A; Kubin R
Respir Med; 1999 Apr; 93(4):252-61. PubMed ID: 10464889
[TBL] [Abstract][Full Text] [Related]
16. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes.
Wilson R; Schentag JJ; Ball P; Mandell L;
Clin Ther; 2002 Apr; 24(4):639-52. PubMed ID: 12017408
[TBL] [Abstract][Full Text] [Related]
17. A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group.
Grossman R; Mukherjee J; Vaughan D; Eastwood C; Cook R; LaForge J; Lampron N
Chest; 1998 Jan; 113(1):131-41. PubMed ID: 9440580
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis.
Langan CE; Zuck P; Vogel F; McIvor A; Peirzchala W; Smakal M; Staley H; Marr C
J Antimicrob Chemother; 1999 Oct; 44(4):515-23. PubMed ID: 10588313
[TBL] [Abstract][Full Text] [Related]
19. A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology.
Kemper P; Köhler D
Am J Med; 1992 Apr; 92(4A):98S-102S. PubMed ID: 1316079
[TBL] [Abstract][Full Text] [Related]
20. Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis.
Bach D; van den Berg-Segers A; Hübner A; van Breukelen G; Cesana M; Plétan Y
J Urol; 1995 Jul; 154(1):19-24. PubMed ID: 7776420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
